Prophylactic use of deoxyspergualin in a quadruple immunosuppressive protocol in renal transplantation
Koyama, I.; Amemiya, H.; Taguchi, Y.; Watanabe, T.; Nagashima, N.; Suzuki, S.; Omoto, R.
Transplantation Proceedings 23(1 Part 2): 1096-1098
1991
ISSN/ISBN: 0041-1345 PMID: 1989158 Document Number: 373090
Document emailed within 1 workday
Related Documents
Heaf, J. 1993: Bone marrow function during quadruple immunosuppressive therapy after renal transplantation Clinical Nephrology 40(6): 332-338Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R. 1989: Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation Transplantation Proceedings 21(1 Part 2): 2258-2259
Rao, K.V.; Andersen, R.C. 1989: The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation Transplantation Proceedings 21(1 Part 2): 1652
Nemoto, K.; Ogino, M.; Ohinata, A.; Hirashima, K. 1997: Unique action of an immunosuppressive agent, deoxyspergualin, on hematopoiesis in mice Experimental Hematology 25(13): 1339-1346
Basić-Jukić, N.; Kes, P. 2011: Novel immunosuppressive drugs in renal transplantation Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 361-364
Ueno, M.; Nakajima, Y.; Kanehiro, H.; Yoshimura, A.; Nakano, H. 1993: Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation Nihon Geka Gakkai Zasshi 94(4): 376-382
Heering, P.; Westhoff, A.; Ivens, K.; Kutkuhn, B.; Grabensee, B. 1994: Reduction of immunosuppressive therapy after renal transplantation: a randomized study Transplantation Proceedings 26(5): 2530-2532
Eklund, B.; Ahonen, J.; Häyry, P.; Kauste, A.; von Willebrand, E.; Lindström, B.L. 1981: Comparison of two different immunosuppressive dosages of methylprednisolone in clinical renal transplantation Scandinavian Journal of Urology and Nephrology. Supplementum 64: 179-184
Caletti, C.; Granata, S.; Tomei, P.; Dalla Gassa, A.; Lupo, A.; Zaza, G. 2015: Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 32(3)
Jiang, H.; Takahara, S.; Li, D.; Namiki, M.; Ishibashi, M.; Okuyama, A.; Sonoda, T. 1994: FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro Transplantation Proceedings 26(4): 2313-2316
Xu, Q.J. 1985: Prophylactic adjunctive use of antilymphocyte globulin in cadaveric renal transplantation Zhonghua Yi Xue Za Zhi 65(4): 215-217
De Pauw, L.; Abramowicz, D.; Goldman, M.; Vereerstraeten, P.; Kinnaert, P.; Toussaint, C. 1990: Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation Transplantation Proceedings 22(4): 1759-1760
Gupta, K.L.; Ghosh, A.K.; Kochhar, R.; Jha, V.; Chakrabarti, A.; Sakhuja, V. 1994: Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols American Journal of Gastroenterology 89(7): 1062-1065
Elli, A.; Rivolta, R.; Palazzi, P.; Mascaretti, L.; Puglisi, G.; Parenti, M.; Sioli, V.; Di Palo, F.Q. 1990: Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects Transplantation Proceedings 22(4): 1689-1690
Fassbinder, W.; Bechstein, P.B.; Scheuermann, E.H.; Schoeppe, W. 1985: Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin Scandinavian Journal of Urology and Nephrology. Supplementum 92: 23-28
Ruffault, A.; Fauconnier, B.; Cartier, F.; Launois, B. 1975: Herpes simplex virus antibodies in 18 patients submitted to immunosuppressive agents after renal transplantation Pathologie-Biologie 23(5): 371-374
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27
Canafax, D.M.; Carleton, B.C.; Matas, A.J.; Payne, W.D.; Dunn, D.L.; Sutherland, D.E.; Najarian, J.S. 1993: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy Transplantation Proceedings 25(1 Pt 2): 1692-1693
Kovarik, J.M.; Rawlings, E.; Sweny, P.; Fernando, O.; Moore, R.; Griffin, P.J.; Fauchald, P.; Albrechtsen, D.; Sodal, G.; Nordal, K.; Amlot, P.L. 1996: Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHi 621 in renal transplantation Transplantation Proceedings 28(2): 913-914
Lloveras, J.; Puig, J.M.; Oliveras, A.; Orfila, A.; Comerma, I.; Aubia, J.; Masramón, J. 1992: Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA Transplantation Proceedings 24(1): 43-44